FASLG and autoimmune polyendocrinopathy: Since then, advancements in our understanding of APS include better characterization of aPL-associated, non-thrombotic clinical manifestations, identification of the role of traditional thrombosis risk factors in aPL-positive individuals, and risk stratification by aPL profile.